Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

By Scott D. Ramsey, Aasthaa Bansal, Catherine Fedorenko, David K. Blough, Karen A. Overstreet, V. Shankaran, P. Newcomb. Journal of Clinical Oncology, 2016

752 citations recorded by the source corpus.

Subfields: Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/247d2e337c864c8df499c91d94f3976b33c0fe7b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. A. Jemal
2. Jiemin Ma
3. A. Mariotto

Citations in the corpus

• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival (2017, background): “The high cost of cancer treatment dubbed “financial toxicity”(110) has been associated with reduced spending on groceries and clothing, skipped medications and physician appointments to save money, bankruptcy, and mortality (111,112).”
• Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016, neutral): “22 Median Brief-POMS (range) 14 (1-50) <.”
• The Financial Burden and Distress of Patients with Cancer: Understanding and Stepping-Up Action on the Financial Toxicity of Cancer Treatment (2018, neutral): “001).(60) Colorectal cancer and prostate can-”